Baxter Hlthcare Corp Company Profile

« Back to Dashboard

What is the competitive landscape for BAXTER HLTHCARE CORP

BAXTER HLTHCARE CORP has eighty-one approved drugs.

There are twenty-six US patents protecting BAXTER HLTHCARE CORP drugs. There are two tentative approvals on BAXTER HLTHCARE CORP drugs.

Summary for Baxter Hlthcare Corp

US Patents:	26
Tradenames:	78
Ingredients:	65
NDAs:	81

Drugs and US Patents for Baxter Hlthcare Corp

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214313-002	Jan 15, 2021	AP	RX	Yes	Yes	12,290,494		Y
Baxter Hlthcare Corp	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214313-005	Feb 6, 2026		RX	Yes	Yes
Baxter Hlthcare Corp	VASOPRESSIN IN SODIUM CHLORIDE 0.9%	vasopressin	SOLUTION;INTRAVENOUS	217569-002	Sep 29, 2023		RX	Yes	Yes	12,447,190		Y
Baxter Hlthcare Corp	KETOROLAC TROMETHAMINE	ketorolac tromethamine	INJECTABLE;INJECTION	075631-002	Jun 29, 2001		DISCN	No	No
Baxter Hlthcare Corp	MICAFUNGIN IN SODIUM CHLORIDE 0.9%	micafungin sodium	SOLUTION;INTRAVENOUS	216142-001	Sep 29, 2023		RX	Yes	Yes	12,403,173		Y
Baxter Hlthcare Corp	METRONIDAZOLE IN PLASTIC CONTAINER	metronidazole	INJECTABLE;INJECTION	078084-001	Mar 31, 2008		DISCN	No	No

Expired US Patents for Baxter Hlthcare Corp

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-003	Feb 24, 1998	6,207,661
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	4,031,894
Baxter Hlthcare Corp	CLINOLIPID 20%	olive oil; soybean oil	EMULSION;INTRAVENOUS	204508-001	Oct 3, 2013	5,840,757
Baxter Hlthcare Corp	DOXIL (LIPOSOMAL)	doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL;INJECTION	050718-002	Jun 13, 2000	5,013,556
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-002	Feb 24, 1998	6,900,184
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-003	Feb 24, 1998	8,133,883

International Patents for Baxter Hlthcare Corp Drugs

Country	Patent Number	Estimated Expiration
Hungary	E066069
Australia	2017376960
World Intellectual Property Organization (WIPO)	2021178946
Portugal	3554474
Japan	2020510619
Japan	2023517926

Supplementary Protection Certificates for Baxter Hlthcare Corp Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1499331	122014000007	Germany		PRODUCT NAME: NATRIUMSULFAT, MAGNESIUMSULFAT UND KALIUMSULFAT; NAT. REGISTRATION NO/DATE: 86203.00.00 20130808; FIRST REGISTRATION: BELGIEN BE434323 20130220
1020461	300482	Netherlands		PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
2563920	CR 2019 00001	Denmark		PRODUCT NAME: INOTERSEN AND SALT THEREOF, INCLUDING SODIUM SALTS; REG. NO/DATE: EU/1/18/1296 20180710
1189916	C300477	Netherlands		PRODUCT NAME: REGADENOSON ALSMEDE FARMACEUTISCHE AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/10/643/001 20100906
0984957	122012000017	Germany		PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
0328535	96C0021	Belgium		PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Baxter Hlthcare
• Baxter Hlthcare Corp